These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12377951)

  • 1. The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1.
    Svensson L; Dahlgren C; Wennerås C
    J Leukoc Biol; 2002 Oct; 72(4):810-8. PubMed ID: 12377951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
    Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
    Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
    Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
    J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.
    Wan HX; Zhou C; Zhang Y; Sun M; Wang X; Yu H; Yang X; Ye RD; Shen JK; Wang MW
    Biochem Pharmacol; 2007 Jul; 74(2):317-26. PubMed ID: 17517377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activation of formyl peptide receptor signaling by peptide ligands.
    Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH
    Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation.
    Yang D; Chen Q; Gertz B; He R; Phulsuksombati M; Ye RD; Oppenheim JJ
    J Leukoc Biol; 2002 Sep; 72(3):598-607. PubMed ID: 12223529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
    Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
    Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
    Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
    Rotrosen D; Malech HL; Gallin JI
    J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
    Dahlgren C; Christophe T; Boulay F; Madianos PN; Rabiet MJ; Karlsson A
    Blood; 2000 Mar; 95(5):1810-8. PubMed ID: 10688842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of neutrophil N-formyl peptide receptors by using antibodies and fluorescent peptides.
    Loitto VM; Rasmusson B; Magnusson KE
    J Leukoc Biol; 2001 May; 69(5):762-71. PubMed ID: 11358985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1.
    Zhou C; Zhang S; Nanamori M; Zhang Y; Liu Q; Li N; Sun M; Tian J; Ye PP; Cheng N; Ye RD; Wang MW
    Mol Pharmacol; 2007 Oct; 72(4):976-83. PubMed ID: 17652444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
    He R; Tan L; Browning DD; Wang JM; Ye RD
    J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional expression of formyl peptide receptor family in human NK cells.
    Kim SD; Kim JM; Jo SH; Lee HY; Lee SY; Shim JW; Seo SK; Yun J; Bae YS
    J Immunol; 2009 Nov; 183(9):5511-7. PubMed ID: 19843937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic and thermodynamic analyses of adhesion of a peptide, Trp-Lys-Tyr-Met-Val-D-Met (WKYMVm), and human formyl peptide receptor (hFPR).
    Cho JH; Cho K; Shin HS
    Biotechnol Lett; 2010 Jun; 32(6):773-9. PubMed ID: 20221845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the formyl peptide chemotactic receptor appearing at the phagocytic cell surface after exposure to phorbol myristate acetate.
    Gardner JP; Melnick DA; Malech HL
    J Immunol; 1986 Feb; 136(4):1400-5. PubMed ID: 3511145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
    Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
    J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of formyl peptide receptor-like 1 by WKYMVm induces serine phosphorylation of STAT3, which inhibits its tyrosine phosphorylation and nuclear translocation induced by hydrogen peroxide.
    Jo EJ; Lee HY; Kim JI; Kang HK; Lee YN; Kwak JY; Bae YS
    Life Sci; 2004 Sep; 75(18):2217-32. PubMed ID: 15325847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.